Relapsed/refractory MCL patients treated with Zanubrutinib

 ABSTRACT   06/2020

For more information about this resource, please submit a medical information request.

Outcomes of relapsed/refractory MCL patients treated with Zanubrutinib monotherapy in the second line and in later lines: A pooled analysis from 2 studies

Rating

Rate this resource

Nice to see you!

For newest details on our EHA materials in a personal video meeting, please click here!
Service